Literature DB >> 25063759

Posterior white matter disease distribution as a predictor of amyloid angiopathy.

Sekh Thanprasertsuk1, Sergi Martinez-Ramirez1, Octavio Marques Pontes-Neto1, Jun Ni1, Alison Ayres1, Anne Reed1, Kyleen Swords1, M Edip Gurol1, Steven M Greenberg1, Anand Viswanathan2.   

Abstract

OBJECTIVES: We sought to examine whether a posterior distribution of white matter hyperintensities (WMH) is an independent predictor of pathologically confirmed cerebral amyloid angiopathy (CAA) and whether it is associated with MRI markers of CAA, in patients without lobar intracerebral hemorrhage.
METHODS: We developed a quantitative method to measure anteroposterior (AP) distribution of WMH. A retrospective cohort of patients without intracerebral hemorrhage and with pathologic evaluation of CAA was examined to determine whether posterior WMH distribution was an independent predictor of CAA (n=59). The relationship of AP distributions of WMH to strictly lobar microbleeds (MBs) (n=259) and location of dilated perivascular spaces (DPVS) (n=85) was examined in a separate cohort of patients evaluated in a memory clinic.
RESULTS: A more posterior WMH distribution was found to be an independent predictor of pathologic evidence of CAA (p=0.001, odds ratio [95% confidence interval]=1.19 [1.07-1.32]), even in the subgroup without lobar MBs (p=0.016, odds ratio [95% confidence interval]=1.18 [1.03-1.36]). In the memory clinic cohort, strictly lobar MBs were independently associated with more posterior WMH distribution (p=0.009). AP distribution of WMH was also associated with location of DPVS (p=0.001), in that patients with predominant DPVS in the white matter over the basal ganglia harbored a more posterior WMH distribution.
CONCLUSIONS: Our results suggest that AP distribution of WMH may represent an additional marker of CAA, irrespective of the presence of lobar hemorrhages. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that there is a significant association between the AP distribution of WMH on MRI with the presence of pathologically confirmed CAA pathology.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 25063759      PMCID: PMC4155043          DOI: 10.1212/WNL.0000000000000732

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  29 in total

1.  Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.

Authors:  K A Knudsen; J Rosand; D Karluk; S M Greenberg
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  Frontal circuitry degradation marks healthy adult aging: Evidence from diffusion tensor imaging.

Authors:  Adolf Pfefferbaum; Elfar Adalsteinsson; Edith V Sullivan
Journal:  Neuroimage       Date:  2005-04-07       Impact factor: 6.556

3.  MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy.

Authors:  S M Greenberg; H C O'Donnell; P W Schaefer; E Kraft
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

4.  Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study.

Authors:  F E de Leeuw; J C de Groot; E Achten; M Oudkerk; L M Ramos; R Heijboer; A Hofman; J Jolles; J van Gijn; M M Breteler
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-01       Impact factor: 10.154

5.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

6.  Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy.

Authors:  M E Gurol; M C Irizarry; E E Smith; S Raju; R Diaz-Arrastia; T Bottiglieri; J Rosand; J H Growdon; S M Greenberg
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

7.  Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study.

Authors:  H Bokura; S Kobayashi; S Yamaguchi
Journal:  J Neurol       Date:  1998-02       Impact factor: 4.849

8.  Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging.

Authors:  Christopher M Holland; Eric E Smith; Istvan Csapo; Mahmut Edip Gurol; Douglas A Brylka; Ronald J Killiany; Deborah Blacker; Marilyn S Albert; Charles R G Guttmann; Steven M Greenberg
Journal:  Stroke       Date:  2008-02-21       Impact factor: 7.914

Review 9.  Alzheimer disease and cerebrovascular pathology: an update.

Authors:  K A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2002-05       Impact factor: 3.575

10.  Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.

Authors:  M W Vernooij; A van der Lugt; M A Ikram; P A Wielopolski; W J Niessen; A Hofman; G P Krestin; M M B Breteler
Journal:  Neurology       Date:  2008-04-01       Impact factor: 9.910

View more
  38 in total

1.  Structural network alterations and neurological dysfunction in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Panagiotis Fotiadis; Sergi Martinez-Ramirez; David H Salat; Aaron Schultz; Ashkan Shoamanesh; Alison M Ayres; Anastasia Vashkevich; Diana Rosas; Kristin Schwab; Alexander Leemans; Geert-Jan Biessels; Jonathan Rosand; Keith A Johnson; Anand Viswanathan; M Edip Gurol; Steven M Greenberg
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

2.  Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.

Authors:  Omar M Al-Janabi; Christopher A Brown; Ahmed A Bahrani; Erin L Abner; Justin M Barber; Brian T Gold; Larry B Goldstein; Ronan R Murphy; Peter T Nelson; Nathan F Johnson; Leslie M Shaw; Charles D Smith; John Q Trojanowski; Donna M Wilcock; Gregory A Jicha
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Diagnostic value of lobar microbleeds in individuals without intracerebral hemorrhage.

Authors:  Sergi Martinez-Ramirez; Jose-Rafael Romero; Ashkan Shoamanesh; Ann C McKee; Ellis Van Etten; Octavio Pontes-Neto; Eric A Macklin; Alison Ayres; Eitan Auriel; Jayandra J Himali; Alexa S Beiser; Charles DeCarli; Thor D Stein; Victor E Alvarez; Matthew P Frosch; Jonathan Rosand; Steven M Greenberg; M Edip Gurol; Sudha Seshadri; Anand Viswanathan
Journal:  Alzheimers Dement       Date:  2015-06-13       Impact factor: 21.566

4.  White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.

Authors:  Seonjoo Lee; Fawad Viqar; Molly E Zimmerman; Atul Narkhede; Giuseppe Tosto; Tammie L S Benzinger; Daniel S Marcus; Anne M Fagan; Alison Goate; Nick C Fox; Nigel J Cairns; David M Holtzman; Virginia Buckles; Bernardino Ghetti; Eric McDade; Ralph N Martins; Andrew J Saykin; Colin L Masters; John M Ringman; Natalie S Ryan; Stefan Förster; Christoph Laske; Peter R Schofield; Reisa A Sperling; Stephen Salloway; Stephen Correia; Clifford Jack; Michael Weiner; Randall J Bateman; John C Morris; Richard Mayeux; Adam M Brickman
Journal:  Ann Neurol       Date:  2016-04-27       Impact factor: 10.422

Review 5.  Diagnosis of Cerebral Amyloid Angiopathy: Evolution of the Boston Criteria.

Authors:  Steven M Greenberg; Andreas Charidimou
Journal:  Stroke       Date:  2018-01-15       Impact factor: 7.914

6.  Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.

Authors:  Gregoire Boulouis; Andreas Charidimou; Michael J Jessel; Li Xiong; Duangnapa Roongpiboonsopit; Panagiotis Fotiadis; Marco Pasi; Alison Ayres; M Emily Merrill; Kristin M Schwab; Jonathan Rosand; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  Neurology       Date:  2017-01-27       Impact factor: 9.910

7.  Cortical superficial siderosis progression in cerebral amyloid angiopathy: Prospective MRI study.

Authors:  Thanakit Pongpitakmetha; Panagiotis Fotiadis; Marco Pasi; Gregoire Boulouis; Li Xiong; Andrew D Warren; Kristin M Schwab; Jonathan Rosand; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Andreas Charidimou
Journal:  Neurology       Date:  2020-04-13       Impact factor: 9.910

8.  Periventricular hyperintensities are associated with elevated cerebral amyloid.

Authors:  Michael Marnane; Osama O Al-Jawadi; Shervin Mortazavi; Kathleen J Pogorzelec; Bing Wei Wang; Howard H Feldman; Ging-Yuek R Hsiung
Journal:  Neurology       Date:  2016-01-08       Impact factor: 9.910

9.  White matter hyperintensity patterns in cerebral amyloid angiopathy and hypertensive arteriopathy.

Authors:  Andreas Charidimou; Gregoire Boulouis; Kellen Haley; Eitan Auriel; Ellis S van Etten; Panagiotis Fotiadis; Yael Reijmer; Alison Ayres; Anastasia Vashkevich; Zora Y Dipucchio; Kristin M Schwab; Sergi Martinez-Ramirez; Jonathan Rosand; Anand Viswanathan; Steven M Greenberg; M Edip Gurol
Journal:  Neurology       Date:  2016-01-08       Impact factor: 9.910

10.  Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation.

Authors:  Andreas Charidimou; Sergi Martinez-Ramirez; Yael D Reijmer; Jamary Oliveira-Filho; Arne Lauer; Duangnapa Roongpiboonsopit; Matthew Frosch; Anastasia Vashkevich; Alison Ayres; Jonathan Rosand; Mahmut Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  JAMA Neurol       Date:  2016-08-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.